Cargando…

Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis

BACKGROUND: Ascites may affect the progression of ovarian cancer (OC). In particular, soluble factors present in OC ascites can create a protective environment for tumor cells that promote de novo resistance to drug- and death receptor-induced apoptosis. However, the underlying molecular mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goncharenko-Khaider, Nadzeya, Matte, Isabelle, Lane, Denis, Rancourt, Claudine, Piché, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526430/ https://www.ncbi.nlm.nih.gov/pubmed/23158473 http://dx.doi.org/10.1186/1476-4598-11-84

Ejemplares similares

Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
por: Lane, Denis, et al.
Publicado: (2012)

The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer
por: Lane, Denis, et al.
Publicado: (2010)

The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells
por: Goncharenko-Khaider, N, et al.
Publicado: (2010)

MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression
por: Matte, Isabelle, et al.
Publicado: (2014)

Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
por: Lane, Denis, et al.
Publicado: (2011)

Role of malignant ascites on human mesothelial cells and their gene expression profiles
por: Matte, Isabelle, et al.
Publicado: (2014)

Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
por: Lane, Denis, et al.
Publicado: (2013)

Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
por: Lane, Denis, et al.
Publicado: (2015)

CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling
por: Lane, Denis, et al.
Publicado: (2016)

Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway
por: Matte, Isabelle, et al.
Publicado: (2019)

Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis
por: Murphy, Á. C., et al.
Publicado: (2013)

MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma
por: Ranjan, Atul, et al.
Publicado: (2018)

ERK Signaling Controls Innate-like CD8(+) T Cell Differentiation via the ELK4 (SAP-1) and ELK1 Transcription Factors
por: Maurice, Diane, et al.
Publicado: (2018)

Integrin-Mediated Adhesion Regulates ERK Nuclear Translocation and Phosphorylation of Elk-1
por: Aplin, Andrew E., et al.
Publicado: (2001)

Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer
por: Booy, E P, et al.
Publicado: (2011)

Mechanical strain promotes skin fibrosis through LRG-1 induction mediated by ELK1 and ERK signalling
por: Gao, Ya, et al.
Publicado: (2019)

Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells
por: Zhu, Zhi-Chuan, et al.
Publicado: (2019)

A-Kinase Anchor Protein 95 Is Involved in ERK1/2–Elk-1 Signal Transduction in Colon Cancer
por: Kong, Xiangyu, et al.
Publicado: (2023)

Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1
por: Zhang, Hong-Mei, et al.
Publicado: (2008)

The Role of EGFR/ERK/ELK-1 MAP Kinase Pathway in the Underlying Damage to Diabetic Rat Skin
por: Ge, Xinhong, et al.
Publicado: (2013)

ERK phosphorylation of MED14 in promoter complexes during mitogen-induced gene activation by Elk-1
por: Galbraith, Matthew D., et al.
Publicado: (2013)

SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1
por: Salinas, Sara, et al.
Publicado: (2004)

Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
por: Lemke, J, et al.
Publicado: (2014)

Bay 61-3606 Sensitizes TRAIL-Induced Apoptosis by Downregulating Mcl-1 in Breast Cancer Cells
por: Kim, So-Young, et al.
Publicado: (2015)

Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells
por: Park, Seong Hye, et al.
Publicado: (2016)

Alternatively spliced isoforms of the human elk-1 mRNA within the 5′ UTR: implications for ELK-1 expression
por: Araud, Tanguy, et al.
Publicado: (2007)

HPV-18 E7 Interacts with Elk-1 Leading to Elevation of the Transcriptional Activity of Elk-1 in Cervical Cancer
por: Go, Sung-Ho, et al.
Publicado: (2022)

Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells
por: Winkler, Marius, et al.
Publicado: (2021)

Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
por: Tolksdorf, Beatrice, et al.
Publicado: (2021)

c‐KIT‐ERK1/2 signaling activated ELK1 and upregulated carcinoembryonic antigen expression to promote colorectal cancer progression
por: Ma, Jian, et al.
Publicado: (2020)

Androgen receptor knockdown enhances prostate cancer chemosensitivity by down‐regulating FEN1 through the ERK/ELK1 signalling pathway
por: Xie, Weijie, et al.
Publicado: (2023)

ELKS1 helps neuronal synapses diversify
por: Short, Ben
Publicado: (2017)

Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway
por: Hou, Chun-Han, et al.
Publicado: (2014)

Diallyl disulphide inhibits apolipoprotein(a) expression in HepG2 cells through the MEK1-ERK1/2-ELK-1 pathway
por: Ma, Xiaofeng, et al.
Publicado: (2017)

SENP1 participates in the dynamic regulation of Elk-1 SUMOylation
por: Witty, James, et al.
Publicado: (2010)

Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors
por: Sale, Matthew J., et al.
Publicado: (2019)

Endogenous Bak inhibitors Mcl-1 and Bcl-x(L): differential impact on TRAIL resistance in Bax-deficient carcinoma
por: Gillissen, Bernhard, et al.
Publicado: (2010)

Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells
por: Jiang, Chunlin, et al.
Publicado: (2015)

Trametinib potentiates TRAIL‐induced apoptosis via FBW7‐dependent Mcl‐1 degradation in colorectal cancer cells
por: Lin, Lin, et al.
Publicado: (2020)

T-cell activation decreases miRNA-15a/16 levels to promote MEK1–ERK1/2–Elk1 signaling and proliferative capacity
por: Urena, Frank, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tekojcrje6holshjuiter39k5o